Drug intelligence / Profile preview

Shenqi Cordyceps Capsule

Development stage
Preclinical
Lead developer
First Affiliated Hospital of Anhui University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Shenqi Cordyceps Capsule is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Anhui University of Chinese Medicine. It is an internal agreement formula (院内协定方) used in the treatment of interstitial lung diseases, including Idiopathic Pulmonary Fibrosis (IPF) and Connective Tissue Disease-associated Interstitial Lung Disease (CTD-ILD). The formulation is based on the 'Yiqi Yangyin Huoxue method' (replenishing qi, nourishing yin, and activating blood circulation), a therapeutic principle in TCM. The capsule contains a combination of traditional Chinese medicinal ingredients, notably ginseng, notoginseng, and cordyceps, which are believed to exert their therapeutic effects through various biological pathways.

Other names
Shenqi Cordyceps参七虫草胶囊
02

Targets

CREBBP (CREB-binding protein)NF-κBHIF1A (Hypoxia-inducible factor 1-alpha)CAT (Catalase)mTOR (Mammalian target of rapamycin kinase)EGFR T790M (Epidermal growth factor receptor T790M mutant)FoxO signaling pathwayNLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Shenqi Cordyceps Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenqi Cordyceps Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call